[1] Escher hypothesizes that the increasing prevalence and strong heritability of autism can in part be explained by non-genetic, environmentally informed events.
Escher has also petitioned the FDA to withdraw approval for two drugs until they can be tested for impacts on developing fetal germ cells.
In 1996, Jill Escher published her master's thesis, A Nightmare on Elm Street?
[5] In 2002, Escher appealed to the Blue Cross Blue Shield Federal Employee Program to provide reimbursement for speech–language services for all autistic individuals, claiming that speech therapy provides benefits to autistic individuals that are equivalent to medicine.
Escher won her appeal and also asked the OPM for a written decision indicating that BCBS was in error.